Clinical Trial Update: Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluates MIT-001 for prevention of oral mucositis in patients undergoing autologous hematopoietic stem cell transplantation. The study lists or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Cancer
• Lymphoma
• Multiple Myeloma
• Oral Mucositis

Drugs mentioned

• MIT-001 (MIT-001)

Snippet

Sponsor: MitoImmune Therapeutics | Conditions: Oral Mucositis, Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING